Source BioScience has an expertise in the development and validation of biomarkers for use as companion diagnostics to support new drug launches or as pharmacodynamic endpoints for clinical and research studies.
We also provide pharmacogenomic and clinical testing services, supporting pre-clinical and clinical trials for different therapeutic areas, with a particular expertise in cancer. The emerging interest in "pharmacogenomics" is comprehensively covered to aid the clinical development of new diagnostic, prognostic and predictive tests as well as supporting drug development pipeline studies from target identification through to clinical trials.
We are GLP, GCP and CPA accredited, with four laboratories in the UK and Ireland, and a further laboratory based in Berlin, providing global clinical trial support. We are the biggest genomics and pathology service provider in the UK and one of a handful of labs worldwide with Illumina CsPro accreditation for excellence in Next Generation sequencing.